Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C

Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C

Background. Despite the introduction of direct antiviral agents, pegylated interferon remains the mainstay of treatment for chronic hepatitis C. However, pegylated interferon is associated with a high rate of severe adverse events and decreased quality of life. Specific interventions can improve adh...

Full description

Bibliographic Details
Main Authors:	Marta Gallach, Mercedes Vergara, Mireia Miquel, Meritxell Casas, Jordi Sánchez-Delgado, Blai Dalmau, Montserrat Gil, Núria Rudi, Isabel Parra, Maria López, Angelina Dosal, Laura Moreno, Oliver Valero, Xavier Calvet
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Annals of Hepatology
Subjects:	Adherence Sustained virological response Interferon Ribavirin Adverse events
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119311408

Similar Items

Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.
by: Marta Gallach, et al.
Published: (2018-01-01)

Correction: Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.
by: Marta Gallach, et al.
Published: (2020-01-01)

Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis
by: Nassim Kamar, et al.
Published: (2016-08-01)

Clinical and basal aspects of anemia during antiviral therapy for hepatitis C
by: Hanneke van Soest, et al.
Published: (2009-10-01)

Therapy of chronic hepatitis C: Virologic response monitoring
by: Kuljić-Kapulica Nada, et al.
Published: (2010-01-01)

Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil
by: Francisco Kennedy Scofoni Faleiros de Azevedo, et al.
Published: (2012-03-01)

Poor response to hepatitis C treatment in elderly patients
by: Ivonete Silva, et al.
Published: (2013-05-01)

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
by: Tseng CW, et al.
Published: (2016-03-01)

Study of the effect of antiviral therapy on homocysteinemia in hepatitis C virus- infected patients
by: Mustafa Mubin, et al.
Published: (2012-08-01)

Retrospective Evaluation of Different Antiviral Treatments for Chronic Hepatitis C Infection
by: Orhan YILDIZ, et al.
Published: (2008-09-01)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020-02-01)

Molde brônquico devido ao uso de interferon peguilado e ribavirina Bronchial casts attributed to the use of pegylated interferon and ribavirin
by: Eduardo Garcia, et al.
Published: (2009-07-01)

Predictors of treatment response in patients with hepatitis C 1b genotype
by: Brjalin Vadim, et al.
Published: (2013-12-01)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
by: Liu Jun-Ying, et al.
Published: (2012-09-01)

Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK)
by: Ahmad Bashir, et al.
Published: (2012-01-01)

Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy
by: Anum Aqsa
Published: (2016-06-01)

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
by: Byung Chul You, et al.
Published: (2012-09-01)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
by: Yadong Wang, et al.
Published: (2022-07-01)

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Edmundo P.A. Lopes, et al.

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
by: Patruno Savino FA, et al.
Published: (2002-08-01)

Porphyria cutanea tarda in an HCV-positive liver transplant patient: a case report
by: Adriano M. Pellicelli, M.D., et al.
Published: (2012-11-01)

Therapy with interferon-a plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Lopes Edmundo P.A., et al.
Published: (2003-01-01)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)

Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review
by: Faydra I. Lieveld, et al.
Published: (2013-05-01)

Hepatitis C virus resistance to interferon therapy: an alarming situation
by: Kanwal Sobia, et al.
Published: (2014-12-01)

Hematological Side Effects During Combination Therapy With Interferon and Ribavirin In Chronic Hepatitis C
by: Komal Owais
Published: (2015-06-01)

Antiviral therapy of chronic hepatitis C: 30 years success story
by: D T Abdurakhmanov, et al.
Published: (2019-11-01)

Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center
by: Karbeyaz F, et al.
Published: (2021-06-01)

Five-year follow-up of patients with chronic C hepatitis and sustained virological response Seguimiento a 5 años de pacientes con hepatitis crónica C y respuesta viral sostenida
by: I. Puig-del-Castillo, et al.
Published: (2011-02-01)

Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial
by: Miguel Ángel Jiménez-Luévano, et al.
Published: (2013-03-01)

Dynamics of hepatitis C virus infection
by: Stefan Zeuzem, M.D., et al.
Published: (2002-04-01)

A Practical Approach to Managing Patients with HCV Infection
Published: (2006-04-01)

Role of Erythropoietin in Adherence to Antiviral Treatment in Hepatitis C
by: Rizwan Ahmed
Published: (2013-06-01)

Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C Oscilaciones de la ferritina sérica asociadas al tratamiento antiviral en la hepatitis crónica por virus C
by: J. M. Ladero, et al.
Published: (2009-01-01)

Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy
by: Giuliano Ramadori, et al.
Published: (2018-03-01)

Disease-Modifying therapy in subacute sclerosing panencephalitis: An area of darkness
by: Divyani Garg, et al.
Published: (2023-01-01)

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin.
by: Mansour Hassan, et al.
Published: (2020-01-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Effectiveness of Direct-Acting Antivirals in Treatment of Elderly Egyptian Chronic Hepatitis C Patients
by: Shimaa Kamel, et al.
Published: (2021-07-01)

Treatment Outcomes of Sofosbuvir/Velpatasvir/Voxilaprevir in Direct-Acting Antiviral-Experienced Hepatitis C Virus Patients: A Systematic Review and Meta-Analysis
by: Pooja Devan, et al.
Published: (2023-06-01)